These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9205086)

  • 1. Glutathione S-transferase expression in hepatitis B virus-associated human hepatocellular carcinogenesis.
    Zhou T; Evans AA; London WT; Xia X; Zou H; Shen F; Clapper ML
    Cancer Res; 1997 Jul; 57(13):2749-53. PubMed ID: 9205086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of GST-pi and HBV infection in hepatocellular carcinoma].
    Shen LJ; Zhang ZJ; Zhang HX; Yang WB; Huang R
    Ai Zheng; 2002 Jan; 21(1):29-32. PubMed ID: 12500393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione S-transferase activity and glutathione S-transferase mu expression in subjects with risk for colorectal cancer.
    Szarka CE; Pfeiffer GR; Hum ST; Everley LC; Balshem AM; Moore DF; Litwin S; Goosenberg EB; Frucht H; Engstrom PF
    Cancer Res; 1995 Jul; 55(13):2789-93. PubMed ID: 7796404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione S-transferase M1 and T1 genetic polymorphisms are not related to the risk of hepatocellular carcinoma: a study in the Spanish population.
    Ladero JM; Martínez C; García-Martín E; Ropero P; Briceño O; Villegas A; Díaz-Rubio M; Agúndez JA
    Eur J Cancer; 2006 Jan; 42(1):73-7. PubMed ID: 16314088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different expression of apoptotic proteins between HBV-infected and non-HBV-infected hepatocellular carcinoma.
    Chang CS; Huang SM; Lin HH; Wu CC; Wang CJ
    Hepatogastroenterology; 2007; 54(79):2061-8. PubMed ID: 18251160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glutathione-S-transferase M1 genotype in patients with hepatocellular carcinoma].
    Deng Z; Wei Y; Ma Y
    Zhonghua Zhong Liu Za Zhi; 2001 Nov; 23(6):477-9. PubMed ID: 11859714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems.
    Massaad L; de Waziers I; Ribrag V; Janot F; Beaune PH; Morizet J; Gouyette A; Chabot GG
    Cancer Res; 1992 Dec; 52(23):6567-75. PubMed ID: 1423302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominance of functional androgen receptor allele with longer CAG repeat in hepatitis B virus-related female hepatocarcinogenesis.
    Yeh SH; Chang CF; Shau WY; Chen YW; Hsu HC; Lee PH; Chen DS; Chen PJ
    Cancer Res; 2002 Aug; 62(15):4346-51. PubMed ID: 12154039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different expression of hepatitis B surface antigen between hepatocellular carcinoma and its surrounding liver tissue, studied using a tissue microarray.
    Wang Y; Wu MC; Sham JS; Tai LS; Fang Y; Wu WQ; Xie D; Guan XY
    J Pathol; 2002 Aug; 197(5):610-6. PubMed ID: 12210080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity.
    Kirk GD; Turner PC; Gong Y; Lesi OA; Mendy M; Goedert JJ; Hall AJ; Whittle H; Hainaut P; Montesano R; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):373-9. PubMed ID: 15734960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of pi class glutathione S-transferase and alpha-fetoprotein in hepatocellular carcinoma and chronic liver disease.
    Yusof YA; Yan KL; Hussain SN
    Anal Quant Cytol Histol; 2003 Dec; 25(6):332-8. PubMed ID: 14714299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues.
    Toussaint C; Albin N; Massaad L; Grunenwald D; Parise O; Morizet J; Gouyette A; Chabot GG
    Cancer Res; 1993 Oct; 53(19):4608-12. PubMed ID: 8402635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues.
    Albin N; Massaad L; Toussaint C; Mathieu MC; Morizet J; Parise O; Gouyette A; Chabot GG
    Cancer Res; 1993 Aug; 53(15):3541-6. PubMed ID: 8339260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The mutation of deletion for glutathione S-transferase M1 gene in the tissue of hepatocellular carcinoma].
    Bian J; Shen F; Wang J; Chen G; Zhang B; Wu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Jun; 16(3):171-3. PubMed ID: 10359869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the glutathione enzyme system of human colon mucosa by localisation, gender and age.
    Hoensch H; Peters WH; Roelofs HM; Kirch W
    Curr Med Res Opin; 2006 Jun; 22(6):1075-83. PubMed ID: 16846540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione transferase activity and isoenzyme composition in primary human breast cancers.
    Shea TC; Claflin G; Comstock KE; Sanderson BJ; Burstein NA; Keenan EJ; Mannervik B; Henner WD
    Cancer Res; 1990 Nov; 50(21):6848-53. PubMed ID: 2208151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of xenobiotic and steroid hormone metabolizing enzymes in hepatocellular tumors of the non-cirrhotic liver.
    Haas S; Merkelbach-Bruse S; Justenhoven C; Brauch H; Fischer HP
    Pathol Res Pract; 2009; 205(10):716-25. PubMed ID: 19596526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of glutathione S-transferase M1, T1, and P1 in patients with HBV-related liver cirrhosis, chronic hepatitis, and normal carriers.
    Mohammadzadeh Ghobadloo S; Yaghmaei B; Allameh A; Hassani P; Noorinayer B; Zali MR
    Clin Biochem; 2006 Jan; 39(1):46-9. PubMed ID: 16316639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.